The Subventricular Zone, a Hideout for Adult and Pediatric High-Grade Glioma Stem Cells

LOMBARD, Arnaud; Di Gregorio, Marina; Delcamp, Clément; Rogister, Bernard; Piette, Caroline; Coppieters't Wallant, Natacha

doi:10.3389/fonc.2020.614930

Download

Article (Scientific journals)

The Subventricular Zone, a Hideout for Adult and Pediatric High-Grade Glioma Stem Cells

LOMBARD, Arnaud; Di Gregorio, Marina; Delcamp, Clément et al.

2021 • In Frontiers in Oncology

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/257707

DOI
10.3389/fonc.2020.614930

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

fonc-10-614930 (1).pdf

Publisher postprint (956.25 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Gliomas; glioblastoma; recurrence; cancer stem cells; subventricular zone

Abstract :

[en] Both in adult and children, high-grade gliomas (WHO grades III and IV) account for a high proportion of death due to cancer. This poor prognosis is a direct consequence of tumor recurrences occurring within few months despite a multimodal therapy consisting of a surgical resection followed by chemotherapy and radiotherapy. There is increasing evidence that glioma stem cells (GSCs) contribute to tumor recurrences. In fact, GSCs can migrate out of the tumor mass and reach the subventricular zone (SVZ), a neurogenic niche persisting after birth. Once nested in the SVZ, GSCs can escape a surgical intervention and resist to treatments. The present review will define GSCs and describe their similarities with neural stem cells, residents of the SVZ. The architectural organization of the SVZ will be described both for humans and rodents. The migratory routes taken by GSCs to reach the SVZ and the signaling pathways involved in their migration will also be described hereafter. In addition, we will debate the advantages of the microenvironment provided by the SVZ for GSCs and how this could contribute to tumor recurrences. Finally, we will discuss the clinical relevance of the SVZ in adult GBM and pediatric HGG and the therapeutic advantages of targeting that neurogenic region in both clinical situations.

Disciplines :

Biochemistry, biophysics & molecular biology

Author, co-author :

LOMBARD, Arnaud ; Centre Hospitalier Universitaire de Liège - CHU > Département de chirurgie > Service de neurochirurgie

Di Gregorio, Marina ; Université de Liège - ULiège > GIGA

Delcamp, Clément ; Université de Liège - ULiège > Neurosciences-Nervous system disorders and therapy

Rogister, Bernard ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biochimie et physiologie générales, et biochimie humaine

Piette, Caroline ; Université de Liège - ULiège > Département des sciences cliniques > Neuropédiatrie

Coppieters't Wallant, Natacha ; Université de Liège - ULiège > Neurosciences-Nervous system disorders and therapy

Language :

English

Title :

The Subventricular Zone, a Hideout for Adult and Pediatric High-Grade Glioma Stem Cells

Publication date :

26 January 2021

Journal title :

Frontiers in Oncology

eISSN :

2234-943X

Publisher :

Frontiers Media S.A., Switzerland

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 07 March 2021

Statistics

Number of views

167 (14 by ULiège)

Number of downloads

155 (10 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, et al. CBTRUS statistical Report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro Oncol (2015) 17:iv1–iv62. doi: 10.1093/neuonc/nov189
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol (2016) 131:803–20. doi: 10.1007/s00401-016-1545-1
Johung T, Monje M. Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets. Curr Neuropharmacol (2017) 15:88–97. doi: 10.2174/1570159x14666160509123229
Sturm D, Bender S, Jones DTW, Lichter P, Grill J, Becher O, et al. Paediatric and adult glioblastoma: Multiform (epi)genomic culprits emerge. Nat Rev Cancer (2014) 14:92–107. doi: 10.1038/nrc3655
Ebrahimi A, Skardelly M, Schuhmann MU, Ebinger M, Reuss D, Neumann M, et al. High frequency of H3 K27M mutations in adult midline gliomas. J Cancer Res Clin Oncol (2019) 145:839–50. doi: 10.1007/s00432-018-02836-5
Luo Y, Zeng L, Xie XQ, Wang F, Liu YZ, Kang JB, et al. H3K27M mutant diffuse midline glioma: A case report. Eur Rev Med Pharmacol Sci (2020) 24:2579–84. doi: 10.26355/eurrev_202003_20527
Schroeder KM, Hoeman CM, Becher OJ. Children are not just little adults: Recent advances in understanding of diffuse intrinsic pontine glioma biology. Pediatr Res (2014) 75:205–9. doi: 10.1038/pr.2013.194
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, et al. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. N Engl J Med (2005) 352:987–96. doi: 10.1056/NEJMoa043330
Lara-Velazquez M, Al-Kharboosh R, Jeanneret S, Vazquez-Ramos C, Mahato D, Tavanaiepour D, et al. Advances in brain tumor surgery for glioblastoma in adults. Brain Sci (2017) 7:166–82. doi: 10.3390/brainsci7120166
David H. Rudolf Virchow and Modern Aspects of Tumor Pathology. Pathol Res Pract (1988) 183:356–64. doi: 10.1016/S0344-0338(88)80138-9
Yi Y, Hsieh IY, Huang X, Li J, Zhao W. Glioblastoma stem-like cells: Characteristics, microenvironment, and therapy. Front Pharmacol (2016) 7:477–91. doi: 10.3389/fphar.2016.00477
Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res (2004) 64:7011–21. doi: 10.1158/0008-5472.CAN-04-1364
Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature (1994) 367:645–8. doi: 10.1038/367645a0
Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature (2004) 432:396–401. doi: 10.1038/nature03128
Brescia P, Richichi C, Pelicci G. Current strategies for identification of glioma stem cells: adequate or unsatisfactory? J Oncol (2012) 2012:376894. doi: 10.1155/2012/376894
Gimple RC, Bhargava S, Dixit D, Rich JN. Glioblastoma stem cells: Lessons from the tumor hierarchy in a lethal cancer. Genes Dev (2019) 33:591–609. doi: 10.1101/gad.324301.119
Suvà ML, Tirosh I. The Glioma Stem Cell Model in the Era of Single-Cell Genomics. Cancer Cell (2020) 37:630–6. doi: 10.1016/j.ccell.2020.04.001
Song W-S, Yang Y-P, Huang C-S, Lu K-H, Liu W-H, Wu W-W, et al. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells. J Chin Med Assoc (2016) 79:538–45. doi: 10.1016/j.jcma.2016.03.010
Caretti V, Bugiani M, Freret M, Schellen P, Jansen M, van Vuurden D, et al. Subventricular spread of diffuse intrinsic pontine glioma. Acta Neuropathol (2014) 128:605–7. doi: 10.1007/s00401-014-1307-x
Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A (2003) 100:15178–83. doi: 10.1073/pnas.2036535100
Goffart N, Lombard A, Lallemand F, Kroonen J, Nassen J, Di Valentin E, et al. CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone. Neuro Oncol (2017) 19:66–77. doi: 10.1093/neuonc/now136
Wang S, Chen C, Li J, Xu X, Chen W, Li F. The CXCL12/CXCR4 axis confers temozolomide resistance to human glioblastoma cells via up-regulation of FOXM1. J Neurol Sci (2020) 414:116837. doi: 10.1016/j.jns.2020.116837
Piccirillo SGM, Spiteri I, Sottoriva A, Touloumis A, Ber S, Price SJ, et al. Contributions to drug resistance in glioblastoma derived from malignant cells in the sub-ependymal zone. Cancer Res (2015) 75:194–202. doi: 10.1158/0008-5472.CAN-13-3131
Dedobbeleer M, Willems E, Freeman S, Lombard A, Goffart N, Rogister B. Phosphatases and solid tumors: Focus on glioblastoma initiation, progression and recurrences. Biochem J (2017) 474:2903–24. doi: 10.1042/BCJ20170112
Blough MD, Westgate MR, Beauchamp D, Kelly JJ, Stechishin O, Ramirez AL, et al. Sensitivity to temozolomide in brain tumor initiating cells. Neuro Oncol (2010) 12:756–60. doi: 10.1093/neuonc/noq032
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature (2006) 444:756. doi: 10.1038/nature05236
Chen J, Li Y, Yu TS, McKay RM, Burns DK, Kernie SG, et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature (2012) 488:522–6. doi: 10.1038/nature11287
Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, et al. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells (2010) 28:5–16. doi: 10.1002/stem.254
Imayoshi I, Sakamoto M, Yamaguchi M, Mori K, Kageyama R. Essential roles of Notch signaling in maintenance of neural stem cells in developing and adult brains. J Neurosci (2010) 30:3489–98. doi: 10.1523/JNEUROSCI.4987-09.2010
Lim DA, Tramontin AD, Trevejo JM, Herrera DG, García-Verdugo JM, Alvarez-Buylla A. Noggin antagonizes BMP signaling to create a niche for adult neurogenesis. Neuron (2000) 28:713–26. doi: 10.1016/S0896-6273(00)00148-3
Lee J, Son MJ, Woolard K, Donin NM, Li A, Cheng CH, et al. Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell (2008) 13:69–80. doi: 10.1016/j.ccr.2007.12.005
Kaur N, Chettiar S, Rathod S, Rath P, Muzumdar D, Shaikh ML, et al. Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma. Mol Cell Neurosci (2013) 54:44–57. doi: 10.1016/j.mcn.2013.01.001
Ming G, Song H. Adult neurogenesis in the mammalian central nervous system. Annu Rev Neurosci (2005) 28:223–50. doi: 10.1146/annurev.neuro.28.051804.101459
Bar EE, Chaudhry A, Lin A, Fan X, Schreck K, Matsui W, et al. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells (2007) 25:2524–33. doi: 10.1634/stemcells.2007-0166
Ahn S, Joyner AL. In vivo analysis of quiescent adult neural stem cells responding to Sonic hedgehog. Nature (2005) 437:894. doi: 10.1038/nature03994
de la Iglesia N, Konopka G, Puram SV, Chan JA, Bachoo RM, You MJ, et al. Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway. Genes Dev (2008) 22:0. doi: 10.1101/gad.1606508
Sherry MM, Reeves A, Wu JK, Cochran BH. STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells. Stem Cells (2009) 27:2383–92. doi: 10.1002/stem.185
Zahonero C, Sánchez-Gómez P. EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy. Cell Mol Life Sci (2014) 71:3465–88. doi: 10.1007/s00018-014-1608-1
Jiang L, Wu J, Yang Y, Liu L, Song L, Li J, et al. Bmi-1 promotes the aggressiveness of glioma via activating the NF-kappaB/MMP-9 signaling pathway. BMC Cancer (2012) 12:406. doi: 10.1186/1471-2407-12-406
Wang J, Wang H, Li Z, Wu Q, Lathia JD, McLendon RE, et al. c-Myc is required for maintenance of glioma cancer stem cells. PloS One (2008) 3:e3769. doi: 10.1371/journal.pone.0003769
Feng R, Zhou S, Liu Y, Song D, Luan Z, Dai X, et al. Sox2 protects neural stem cells from apoptosis via up-regulating survivin expression. Biochem J (2013) 450:459–68. doi: 10.1042/BJ20120924
Ligon KL, Huillard E, Mehta S, Kesari S, Liu H, Alberta JA, et al. Olig2-Regulated Lineage-Restricted Pathway Controls Replication Competence in Neural Stem Cells and Malignant Glioma. Neuron (2007) 53:503–17. doi: 10.1016/j.neuron.2007.01.009
Mehta S, Huillard E, Kesari S, Maire CL, Golebiowski D, Harrington EP, et al. The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant glioma. Cancer Cell (2011) 19:359–71. doi: 10.1016/j.ccr.2011.01.035
Vermeulen L, de Sousa e Melo F, Richel DJ, Medema JP. The developing cancer stem-cell model: clinical challenges and opportunities. Lancet Oncol (2012) 13:e83–9. doi: 10.1016/S1470-2045(11)70257-1
Kroonen J, Nassen J, Boulanger Y-G, Provenzano F, Capraro V, Bours V, et al. Human glioblastoma-initiating cells invade specifically the subventricular zones and olfactory bulbs of mice after striatal injection. Int J Cancer (2011) 129:574–85. doi: 10.1002/ijc.25709
Goffart N, Kroonen J, Di Valentin E, Dedobbeleer M, Denne A, Martinive P, et al. Adult mouse subventricular zones stimulate glioblastoma stem cells specific invasion through CXCL12/CXCR4 signaling. Neuro Oncol (2015) 17:81–94. doi: 10.1093/neuonc/nou144
Qin EY, Cooper DD, Abbott KL, Lennon J, Nagaraja S, Mackay A, et al. Neural Precursor-Derived Pleiotrophin Mediates Subventricular Zone Invasion by Glioma. Cell (2017) 170:845–59.e19. doi: 10.1016/j.cell.2017.07.016
Yeh AC, Ramaswamy S. Mechanisms of cancer cell dormancy-another hallmark of cancer? Cancer Res (2015) 75:5014–22. doi: 10.1158/0008-5472.CAN-15-1370
Marlier Q, Verteneuil S, Vandenbosch R, Malgrange B. Mechanisms and functional significance of stroke-induced neurogenesis. Front Neurosci (2015) 9:458. doi: 10.3389/fnins.2015.00458
Barnabé-Heider F, Göritz C, Sabelström H, Takebayashi H, Pfrieger FW, Meletis K, et al. Origin of new glial cells in intact and injured adult spinal cord. Cell Stem Cell (2010) 7:470–82. doi: 10.1016/j.stem.2010.07.014
Pellegrino G, Trubert C, Terrien J, Pifferi F, Leroy D, Loyens A, et al. A comparative study of the neural stem cell niche in the adult hypothalamus of human, mouse, rat and gray mouse lemur (Microcebus murinus). J Comp Neurol (2018) 526:1419–43. doi: 10.1002/cne.24376
Chesler DA, Berger MS, Quinones-Hinojosa A. The potential origin of glioblastoma initiating cells. Front Biosci - Schol Ed (2012) 4 S:190–205. doi: 10.2741/s261
Quiñones-Hinojosa A, Chaichana K. The human subventricular zone: A source of new cells and a potential source of brain tumors. Exp Neurol (2007) 205:313–24. doi: 10.1016/j.expneurol.2007.03.016
Dulken BW, Leeman DS, Boutet SC, Hebestreit K, Brunet A. Single-Cell Transcriptomic Analysis Defines Heterogeneity and Transcriptional Dynamics in the Adult Neural Stem Cell Lineage. Cell Rep (2017) 18:777–90. doi: 10.1016/j.celrep.2016.12.060
Kriegstein A, Alvarez-Buylla A. The glial nature of embryonic and adult neural stem cells. Annu Rev Neurosci (2009) 32:149–84. doi: 10.1146/annurev.neuro.051508.135600
Wang S, Chandler-Militello D, Lu G, Roy NS, Zielke A, Auvergne R, et al. Prospective identification, isolation, and profiling of a telomerase-expressing subpopulation of human neural stem cells, using sox2 enhancer-directed fluorescence-activated cell sorting. J Neurosci (2010) 30:14635–48. doi: 10.1523/JNEUROSCI.1729-10.2010
Codega P, Silva-Vargas V, Paul A, Maldonado-Soto AR, DeLeo AM, Pastrana E, et al. Prospective Identification and Purification of Quiescent Adult Neural Stem Cells from Their In Vivo Niche. Neuron (2014) 82:545–59. doi: 10.1016/j.neuron.2014.02.039
Michaelidesová A, Konířová J, Bartůněk P, Zíková M. Effects of Radiation Therapy on Neural Stem Cells. Genes (Basel) (2019) 10:640. doi: 10.3390/genes10090640
Brazel CY, Limke TL, Osborne JK, Miura T, Cai J, Pevny L, et al. Sox2 expression defines a heterogeneous population of neurosphere-forming cells in the adult murine brain. Aging Cell (2005) 4:197–207. doi: 10.1111/j.1474-9726.2005.00158.x
Dennis CV, Suh LS, Rodriguez ML, Kril JJ, Sutherland GT. Human adult neurogenesis across the ages: An immunohistochemical study. Neuropathol Appl Neurobiol (2016) 42:621–38. doi: 10.1111/nan.12337
Barry G, Guennewig B, Fung S, Kaczorowski D, Weickert CS. Long non-coding RNA expression during aging in the human subependymal zone. Front Neurol (2015) 6:45–55. doi: 10.3389/fneur.2015.00045
Smith AM, Dragunow M. The human side of microglia. Trends Neurosci (2014) 37:125–35. doi: 10.1016/j.tins.2013.12.001
Coletti AM, Singh D, Kumar S, Shafin TN, Briody PJ, Babbitt BF, et al. Characterization of the ventricular-subventricular stem cell niche during human brain develovnpment. Dev (2018) 145:145–57. doi: 10.1242/dev.170100
Obernier K, Alvarez-Buylla A. Neural stem cells: Origin, heterogeneity and regulation in the adult mammalian brain. Dev (2019) 146. doi: 10.1242/dev.156059
Ponti G, Obernier K, Guinto C, Jose L, Bonfanti L, Alvarez-Buylla A. Cell cycle and lineage progression of neural progenitors in the ventricular-subventricular zones of adult mice. Proc Natl Acad Sci U S A (2013) 110:1045–54. doi: 10.1073/pnas.1219563110
Scherer HJ. Structural development in gliomas. Am J Cancer (1938) 34:333–51. doi: 10.1158/ajc.1938.333
Sampetrean O, Saga I, Nakanishi M, Sugihara E, Fukaya R, Onishi N, et al. Invasion precedes tumor mass formation in a malignant brain tumor model of genetically modified neural stem cells. Neoplasia (2011) 13:784–91. doi: 10.1593/neo.11624
Cuddapah VA, Robel S, Watkins S, Sontheimer H. A neurocentric perspective on glioma invasion. Nat Rev Neurosci (2014) 15:455–65. doi: 10.1038/nrn3765
Kakita A, Zerlin M, Takahashi H, Goldman JE. Some glial progenitors in the neonatal subventricular zone migrate through the corpus callosum to the contralateral cerebral hemisphere. J Comp Neurol (2003) 458:381–8. doi: 10.1002/cne.10597
Sharifi G, Pajavand AM, Nateghinia S, Meybodi TE, Hasooni H. Glioma Migration Through the Corpus Callosum and the Brainstem Detected by Diffusion and Magnetic Resonance Imaging: Initial Findings. Front Hum Neurosci (2020) 13:472. doi: 10.3389/fnhum.2019.00472
Dillen Y, Kemps H, Gervois P, Wolfs E, Bronckaers A. Adult Neurogenesis in the Subventricular Zone and Its Regulation After Ischemic Stroke: Implications for Therapeutic Approaches. Transl Stroke Res (2020) 11:60–79. doi: 10.1007/s12975-019-00717-8
Meyrath M, Szpakowska M, Zeiner J, Massotte L, Merz MP, Benkel T, et al. The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides. Nat Commun (2020) 11:1–16. doi: 10.1038/s41467-020-16664-0
Yang L, Jackson E, Woerner BM, Perry A, Piwnica-Worms D, Rubin JB. Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo. Cancer Res (2007) 67:651–8. doi: 10.1158/0008-5472.CAN-06-2762
Rubin JB, Kung AL, Klein RS, Chan JA, Sun YP, Schmidt K, et al. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci U S A (2003) 100:13513–8. doi: 10.1073/pnas.2235846100
Lee CC, Lai JH, Hueng DY, Ma HI, Chung YC, Sun Yy, et al. Disrupting the CXCL12/CXCR4 axis disturbs the characteristics of glioblastoma stem-like cells of rat RG2 glioblastoma. Cancer Cell Int (2013) 13:85. doi: 10.1186/1475-2867-13-85
Würth R, Bajetto A, Harrison JK, Barbieri F, Florio T. CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment. Front Cell Neurosci (2014) 8:1–19. doi: 10.3389/fncel.2014.00144
Zhu Y, Yang P, Wang Q, Hu J, Xue J, Li G, et al. The effect of CXCR4 silencing on epithelial-mesenchymal transition related genes in glioma U87 cells. Anat Rec (2013) 296:1850–6. doi: 10.1002/ar.22821
Dedobbeleer M, Willems E, Lambert J, Lombard A, Digregorio M, Lumapat PN, et al. MKP1 phosphatase is recruited by CXCL12 in glioblastoma cells and plays a role in DNA strand breaks repair. Carcinogenesis (2019) 41(4):417–29. doi: 10.1093/carcin/bgz151
Willems E, Dedobbeleer M, Digregorio M, Lombard A, Goffart N, Lumapat PN, et al. Aurora A plays a dual role in migration and survival of human glioblastoma cells according to the CXCL12 concentration. Oncogene (2019) 38:73–87. doi: 10.1038/s41388-018-0437-3
Kjell J, Fischer-Sternjak J, Thompson AJ, Friess C, Sticco MJ, Salinas F, et al. Defining the Adult Neural Stem Cell Niche Proteome Identifies Key Regulators of Adult Neurogenesis. Cell Stem Cell (2020) 26:277–93.e8. doi: 10.1016/j.stem.2020.01.002
Mcginn MJ, Colello RJ, Sun D. Age-related proteomic changes in the subventricular zone and their association with neural stem/progenitor cell proliferation. J Neurosci Res (2012) 90:1159–68. doi: 10.1002/jnr.23012
Fietz SA, Lachmann R, Brandl H, Kircher M, Samusik N, Lakshmanaperumal N, et al. Transcriptomes of germinal zones of human and mouse fetal neocortex suggest a role of extracellular matrix in progenitor self-renewal. Proc Natl Acad Sci U S A (2012) 109:11836–41. doi: 10.1073/pnas.1209647109
Miller JA, Ding SL, Sunkin SM, Smith KA, Ng L, Szafer A, et al. Transcriptional landscape of the prenatal human brain. Nature (2014) 508:199–206. doi: 10.1038/nature13185
Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, et al. Functional organization of the transcriptome in human brain. Nat Neurosci (2008) 11:1271–82. doi: 10.1038/nn.2207
Tome-Garcia J, Tejero R, Nudelman G, Yong RL, Sebra R, Wang H, et al. Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties. Stem Cell Rep (2017) 8:1421–9. doi: 10.1016/j.stemcr.2017.03.019
Okawa S, Gagrica S, Blin C, Ender C, Pollard SM, Krijgsveld J. Proteome and Secretome Characterization of Glioblastoma-Derived Neural Stem Cells. Stem Cells (2017) 35:967–80. doi: 10.1002/stem.2542
Vied CM, Freudenberg F, Wang Y, Raposo AASF, Feng D, Nowakowski RS. A multi-resource data integration approach: Identifcation of candidate genes regulating cell proliferation during neocortical development. Front Neurosci (2014) 8:257. doi: 10.3389/fnins.2014.00257
Mirzadeh Z, Merkle FT, Soriano-Navarro M, Garcia-Verdugo JM, Alvarez-Buylla A. Neural Stem Cells Confer Unique Pinwheel Architecture to the Ventricular Surface in Neurogenic Regions of the Adult Brain. Cell Stem Cell (2008) 3:265–78. doi: 10.1016/j.stem.2008.07.004
Schiffer D, Annovazzi L, Casalone C, Corona C, Mellai M. Glioblastoma: Microenvironment and niche concept. Cancers (Basel) (2019) 11:5–23. doi: 10.3390/cancers11010005
Sinnaeve J, Mobley BC, Ihrie RA. Space Invaders: Brain Tumor Exploitation of the Stem Cell Niche. Am J Pathol (2018) 188:29–38. doi: 10.1016/j.ajpath.2017.08.029
Goffart N, Kroonen J, Rogister B. Glioblastoma-initiating cells: Relationship with neural stem cells and the micro-environment. Cancers (Basel) (2013) 5:1049–71. doi: 10.3390/cancers5031049
Arvanitis CD, Ferraro GB, Jain RK. The blood–brain barrier and blood–tumour barrier in brain tumours and metastases. Nat Rev Cancer (2020) 20:26–41. doi: 10.1038/s41568-019-0205-x
Xu C, Liu X, Geng Y, Bai Q, Pan C, Sun Y, et al. Patient-derived DIPG cells preserve stem-like characteristics and generate orthotopic tumors. Oncotarget (2017) 8:76644–55. doi: 10.18632/oncotarget.19656
Cameron BD, Traver G, Roland JT, Brockman AA, Dean D, Johnson L, et al. Bcl2-Expressing Quiescent Type B Neural Stem Cells in the Ventricular-Subventricular Zone Are Resistant to Concurrent Temozolomide/X-Irradiation. Stem Cells (2019) 37:1629–39. doi: 10.1002/stem.3081
Kokovay E, Goderie S, Wang Y, Lotz S, Lin G, Sun Y, et al. Adult SVZ lineage cells home to and leave the vascular niche via differential responses to SDF1/CXCR4 signaling. Cell Stem Cell (2010) 7:163–73. doi: 10.1016/j.stem.2010.05.019
Rajendiran S, Smith-Berdan S, Kunz L, Risolino M, Selleri L, Schroeder T, et al. Ubiquitous overexpression of CXCL12 confers radiation protection and enhances mobilization of hematopoietic stem and progenitor cells. Stem Cells (2020) 38(9)1159–74. doi: 10.1002/stem.3205
Krathwohl MD, Kaiser JL. Chemokines promote quiescence and survival of human neural progenitor cells. Stem Cells (2004) 22:109–18. doi: 10.1634/stemcells.22-1-109
Erreni M, Solinas G, Brescia P, Osti D, Zunino F, Colombo P, et al. Human glioblastoma tumours and neural cancer stem cells express the chemokine CX3CL1 and its receptor CX3CR1. Eur J Cancer (2010) 46:3383–92. doi: 10.1016/j.ejca.2010.07.022
Alafate W, Li X, Zuo J, Zhang H, Xiang J, Wu W, et al. Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma. CNS Neurosci Ther (2020) 26:475–85. doi: 10.1111/cns.13297
Morizur L, Chicheportiche A, Gauthier LR, Daynac M, Boussin FD, Mouthon MA. Distinct Molecular Signatures of Quiescent and Activated Adult Neural Stem Cells Reveal Specific Interactions with Their Microenvironment. Stem Cell Rep (2018) 11:565–77. doi: 10.1016/j.stemcr.2018.06.005
Chen Q, Cai J, Jiang C. CDH2 expression is of prognostic significance in glioma and predicts the efficacy of temozolomide therapy in patients with glioblastoma. Oncol Lett (2018) 15:7415–22. doi: 10.3892/ol.2018.8227
Mohyeldin A, Garzón-Muvdi T, Quiñones-Hinojosa A. Oxygen in stem cell biology: A critical component of the stem cell niche. Cell Stem Cell (2010) 7:150–61. doi: 10.1016/j.stem.2010.07.007
Zhang K, Zhou Y, Zhao T, Wu L, Huang X, Wu K, et al. Reduced Cerebral Oxygen Content in the DG and SVZ In Situ Promotes Neurogenesis in the Adult Rat Brain In Vivo. Plos ONE (2015) 10:e0140035. doi: 10.1371/journal.pone.0140035
Mas-Bargues C, Sanz-Ros J, Román-Domínguez A, Inglés M, Gimeno-Mallench L, El Alami M, et al. Relevance of oxygen concentration in stem cell culture for regenerative medicine. Int J Mol Sci (2019) 20:1195–222. doi: 10.3390/ijms20051195
Cavallucci V, Fidaleo M, Pani G. Neural Stem Cells and Nutrients: Poised Between Quiescence and Exhaustion. Trends Endocrinol Metab (2016) 27:756–69. doi: 10.1016/j.tem.2016.06.007
Lim DA, Cha S, Mayo MC, Chen M-H, Keles E, VandenBerg S, et al. Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro Oncol (2007) 9:424–9. doi: 10.1215/15228517-2007-023
Chaichana KL, McGirt MJ, Frazier J, Attenello F, Guerrero-Cazares H, Quinones-Hinojosa A. Relationship of glioblastoma multiforme to the lateral ventricles predicts survival following tumor resection. J Neurooncol (2008) 89:219–24. doi: 10.1007/s11060-008-9609-2
Sonoda Y, Saito R, Kanamori M, Kumabe T, Uenohara H, Tominaga T. The association of subventricular zone involvement at recurrence with survival after repeat surgery in patients with recurrent glioblastoma. Neurol Med Chir (Tokyo) (2014) 54:302–9. doi: 10.2176/nmc.oa.2013-0226
Adeberg S, Bostel T, König L, Welzel T, Debus J, Combs SE. A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival? Radiat Oncol (2014) 9:95. doi: 10.1186/1748-717X-9-95
Jafri NF, Clarke JL, Weinberg V, Barani IJ, Cha S. Relationship of glioblastoma multiforme to the subventricular zone is associated with survival. Neuro Oncol (2013) 15:91–6. doi: 10.1093/neuonc/nos268
Mistry AM, Dewan MC, White-Dzuro GA, Brinson PR, Weaver KD, Thompson RC, et al. Decreased survival in glioblastomas is specific to contact with the ventricular-subventricular zone, not subgranular zone or corpus callosum. J Neurooncol (2017) 132:341–9. doi: 10.1007/s11060-017-2374-3
Mistry AM, Hale AT, Chambless LB, Weaver KD, Thompson RC, Ihrie RA. Influence of glioblastoma contact with the lateral ventricle on survival: a meta-analysis. J Neurooncol (2017) 131:125–33. doi: 10.1007/s11060-016-2278-7
Han S, Li X, Qiu B, Jiang T, Wu A. Can lateral ventricle contact predict the ontogeny and prognosis of glioblastoma? J Neurooncol (2015) 124:45–55. doi: 10.1007/s11060-015-1818-x
Mistry AM, Wooten DJ, Davis LT, Mobley BC, Quaranta V, Ihrie RA. Ventricular-Subventricular Zone Contact by Glioblastoma is Not Associated with Molecular Signatures in Bulk Tumor Data. Sci Rep (2019) 9:1–12. doi: 10.1038/s41598-018-37734-w
Comas S, Luguera E, Molero J, Balaña C, Estival A, Castañer S, et al. Influence of glioblastoma contact with the subventricular zone on survival and recurrence patterns. Clin Transl Oncol (2020), 1–11. doi: 10.1007/s12094-020-02448-x
Mistry AM, Mummareddy N, CreveCoeur TS, Lillard JC, Vaughn BN, Gallant J-N, et al. Association between supratentorial pediatric high-grade gliomas involved with the subventricular zone and decreased survival: a multi-institutional retrospective study. J Neurosurg Pediatr (2020) 1–7:288–94. doi: 10.3171/2020.3.peds19593
Pessina F, Navarria P, Cozzi L, Ascolese AM, Simonelli M, Santoro A, et al. Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience. J Neurooncol (2017) 135:129–39. doi: 10.1007/s11060-017-2559-9
Jackson C, Choi J, Khalafallah AM, Price C, Bettegowda C, Lim M, et al. A systematic review and meta-analysis of supratotal versus gross total resection for glioblastoma. J Neurooncol (2020) 148:1–13. doi: 10.1007/s11060-020-03556-y
Elliott JP, Keles GE, Waite M, Temkin N, Berger MS. Ventricular entry during resection of malignant gliomas: effect on intracranial cerebrospinal fluid tumor dissemination. J Neurosurg (1994) 80:834–9. doi: 10.3171/jns.1994.80.5.0834
Behling F, Kaltenstadler M, Noell S, Schittenhelm J, Bender B, Eckert F, et al. The prognostic impact of ventricular opening in glioblastoma surgery: a retrospective single center analysis. World Neurosurg (2017) 106:615–24. doi: 10.1016/j.wneu.2017.07.034
Saito T, Muragaki Y, Maruyama T, Komori T, Nitta M, Tsuzuki S, et al. Influence of wide opening of the lateral ventricle on survival for supratentorial glioblastoma patients with radiotherapy and concomitant temozolomide-based chemotherapy. Neurosurg Rev (2019) 1:1–11. doi: 10.1093/noajnl/vdz039.087
Smith AW, Mehta MP, Wernicke AG. Neural stem cells, the subventricular zone and radiotherapy: implications for treating glioblastoma. J Neurooncol (2016) 128:207–16. doi: 10.1007/s11060-016-2123-z
Evers P, Lee PP, DeMarco J, Agazaryan N, Sayre JW, Selch M, et al. Irradiation of the potential cancer stem cell niches in the adult brain improves progression-free survival of patients with malignant glioma. BMC Cancer (2010) 10:1–7. doi: 10.1186/1471-2407-10-384
Gupta T, Nair V, Paul SN, Kannan S, Moiyadi A, Epari S, et al. Can irradiation of potential cancer stem-cell niche in the subventricular zone influence survival in patients with newly diagnosed glioblastoma? J Neurooncol (2012) 109:195–203. doi: 10.1007/s11060-012-0887-3
Lee P, Eppinga W, Lagerwaard F, Cloughesy T, Slotman B, Nghiemphu PL, et al. Evaluation of high ipsilateral subventricular zone radiation therapy dose in glioblastoma: A pooled analysis. Int J Radiat Oncol Biol Phys (Elsevier) (2013) 86:609–15. doi: 10.1016/j.ijrobp.2013.01.009
Chen L, Guerrero-Cazares H, Ye X, Ford E, McNutt T, Kleinberg L, et al. Increased subventricular zone radiation dose correlates with survival in glioblastoma patients after gross total resection. Int J Radiat Oncol Biol Phys (Elsevier) (2013) 86:616–22. doi: 10.1016/j.ijrobp.2013.02.014
Iuchi T, Hatano K, Kodama T, Sakaida T, Yokoi S, Kawasaki K, et al. Phase 2 trial of hypofractionated high-dose intensity modulated radiation therapy with concurrent and adjuvant temozolomide for newly diagnosed glioblastoma. Int J Radiat Oncol Biol Phys (2014) 88:793–800. doi: 10.1016/j.ijrobp.2013.12.011
Ravind RR, Prameela CG, Dinesh M. P0111 Sub-ventricular zone irradiation in glioblastoma: Can it increase survival? Eur J Cancer (2015) 51:e23. doi: 10.1016/j.ejca.2015.06.069
Foro P, Pera O, De Dios NR, Sanz J, Castillejo AR, Conejo IM, et al. Relationship Between Subventricular Zone Dose and Survival in Patients With Glioblastoma Multiforme Treated With Surgery Followed Radiation Chemotherapy. Int J Radiat Oncol (2015) 93:E81. doi: 10.1016/j.ijrobp.2015.07.752
Foro Arnalot P, Pera O, Rodriguez N, Sanz X, Reig A, Membrive I, et al. Influence of incidental radiation dose in the subventricular zone on survival in patients with glioblastoma multiforme treated with surgery, radiotherapy, and temozolomide. Clin Transl Oncol (2017) 19:1225–31. doi: 10.1007/s12094-017-1659-5
Slotman BJ, Eppinga WSC, de Haan PF, Lagerwaard FJ. Is Irradiation of Potential Cancer Stem Cell Niches in the Subventricular Zones Indicated in GBM? Int J Radiat Oncol (2011) 81:S184. doi: 10.1016/j.ijrobp.2011.06.328
Elicin O, Inac E, Uzel EK, Karacam S, Uzel OE. Relationship between survival and increased radiation dose to subventricular zone in glioblastoma is controversial. J Neurooncol (2014) 118:413–9. doi: 10.1007/s11060-014-1424-3
Anker CJ, Bagshaw HP, Sarkar V, Dritto M, Boucher K, Jensen RL, et al. Impact of Subventricular Zone Dose and Relationship to Glioblastoma Tumor Location on Outcomes. Int J Radiat Oncol (2015) 93:E110–1. doi: 10.1016/j.ijrobp.2015.07.829
Sakuramachi M, Igaki H, Nomoto A, Sekiya N, Takahashi W, Sakumi A, et al. Radiation Dose to Ipsilateral Subventricular Zone as a Prognostic Factor in Malignant Glioma Patients. Int J Radiat Oncol (2015) 93:E68. doi: 10.1016/j.ijrobp.2015.07.716
Murchison SC, Wiksyk B, Gossman S, Jensen B, Sayers D, Lesperance M, et al. Subventricular Zone Radiation Dose and Outcome for Glioblastoma Treated Between 2006 and 2012. Cureus (2018) 10:3618–31. doi: 10.7759/cureus.3618
Valiyaveettil D, Malik M, Joseph DM. Effect of radiation dose to the periventricular zone and subventricular zone on survival in anaplastic gliomas. Ecancermedicalscience (2019) 13. doi: 10.3332/ecancer.2019.956
Valiyaveettil D, Malik M, Syed K, Fayaz Ahmed S, Joseph DM. Prospective study to assess the survival outcomes of planned irradiation of ipsilateral subventricular and periventricular zones in glioblastoma. Ecancermedicalscience (2020) 14:1021–32. doi: 10.3332/ecancer.2020.1021
Khalifa J, Tensaouti F, Lusque A, Plas B, Lotterie JA, Benouaich-Amiel A, et al. Subventricular zones: New key targets for glioblastoma treatment. Radiat Oncol (2017) 12:1–11. doi: 10.1186/s13014-017-0791-2
Gui C, Vannorsdall TD, Kleinberg LR, Assadi R, Moore JA, Hu C, et al. A Prospective Cohort Study of Neural Progenitor Cell-Sparing Radiation Therapy Plus Temozolomide for Newly Diagnosed Patients With Glioblastoma. Neurosurgery (2020) 87:E31–40. doi: 10.1093/neuros/nyaa107
Hsiao KY, Yeh SA, Chang CC, Tsai PC, Wu JM, Gau JS. Cognitive Function Before and After Intensity-Modulated Radiation Therapy in Patients With Nasopharyngeal Carcinoma: A Prospective Study. Int J Radiat Oncol Biol Phys (2010) 77:722–6. doi: 10.1016/j.ijrobp.2009.06.080
Jalali R, Mallick I, Dutta D, Goswami S, Gupta T, Munshi A, et al. Factors Influencing Neurocognitive Outcomes in Young Patients With Benign and Low-Grade Brain Tumors Treated With Stereotactic Conformal Radiotherapy. Int J Radiat Oncol Biol Phys (2010) 77:974–9. doi: 10.1016/j.ijrobp.2009.06.025
Armstrong GT, Jain N, Liu W, Merchant TE, Stovall M, Srivastava DK, et al. Region-specific radiotherapy and neuropsychological outcomes in adult survivors of childhood CNS malignancies. Neuro Oncol (2010) 12:1173–86. doi: 10.1093/neuonc/noq104
Khatua S, Dhall G, O’Neil S, Jubran R, Villablanca JG, Marachelian A, et al. Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation. Pediatr Blood Cancer (2010) 55:n/a–a. doi: 10.1002/pbc.22468
Sharifzad F, Ghavami S, Verdi J, Mardpour S, Sisakht MM, Azizi Z, et al. Glioblastoma cancer stem cell biology: Potential theranostic targets Corresponding author at: Paediatric Stem Cell Transplant. Drug Resist Update (2019) 42:35–45. doi: 10.1016/j.drup.2018.03.003
Kast RE, Ellingson BM, Marosi C, Halatsch ME. Glioblastoma treatment using perphenazine to block the subventricular zone’s tumor trophic functions. J Neurooncol (2014) 116:207–12. doi: 10.1007/s11060-013-1308-y
O’Keeffe GC, Tyers P, Aarsland D, Dalley JW, Barker RA, Caldwellf MA. Dopamine-induced proliferation of adult neural precursor cells in the mammalian subventricular zone is mediated through EGF. Proc Natl Acad Sci U S A (2009) 106:8754–9. doi: 10.1073/pnas.0803955106
Bardella C, Al-Shammari AR, Soares L, Tomlinson I, O’Neill E, Szele FG. The role of inflammation in subventricular zone cancer. Prog Neurobiol (2018) 170:37–52. doi: 10.1016/j.pneurobio.2018.04.007
Roesch S, Rapp C, Dettling S, Herold-Mende C. When immune cells turn bad—tumor-associated microglia/macrophages in glioma. Int J Mol Sci (2018) 19:436–56. doi: 10.3390/ijms19020436
Van Der Sanden B, Appaix F, Berger F, Selek L, Issartel JP, Wion D. Translation of the ecological trap concept to glioma therapy: The cancer cell trap concept. Future Oncol (2013) 9:817–24. doi: 10.2217/fon.13.30
Azarin SM, Yi J, Gower RM, Aguado BA, Sullivan ME, Goodman AG, et al. In vivo capture and label-free detection of early metastatic cells. Nat Commun (2015) 6:1–9. doi: 10.1038/ncomms9094
Rao SS, Bushnell GG, Azarin SM, Spicer G, Aguado BA, Stoehr JR, et al. Enhanced survival with implantable scaffolds that capture metastatic breast cancer cells in vivo. Cancer Res (2016) 76:5209–18. doi: 10.1158/0008-5472.CAN-15-2106